A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Pathogens evade adaptive immunity through antigenic variation (point mutations gradually changing surface antigens, as in influenza drift), antigenic shift (reassortment creating new subtypes), and antigenic mimicry (expressing surface molecules resembling host). These strategies allow re-infection with the same pathogen and explain why vaccines must be updated and why some infections are chronic.
Study influenza antigenic drift and shift and their epidemiological impact. Examine molecular mimicry in bacterial and viral pathogens.
Antigenic variation is not random; it occurs at hot spots in surface proteins. Not all variation escapes immunity—some is chemically conservative and does not reduce antibody recognition.
From your study of host-pathogen interactions and adaptive immunity, you know that the immune system generates highly specific antibodies and T cell receptors that recognize particular molecular shapes — epitopes — on pathogen surfaces. This specificity is the immune system's greatest strength, but it also creates a vulnerability that pathogens ruthlessly exploit: if a pathogen can change the shape of its surface molecules, the immune system's carefully tailored weapons no longer fit, and the pathogen escapes detection.
Antigenic drift is the gradual accumulation of point mutations in genes encoding surface proteins. Influenza provides the textbook example: the viral surface protein hemagglutinin (HA) accumulates amino acid substitutions in the regions that antibodies bind. Each mutation slightly alters the epitope's shape. After enough mutations accumulate, antibodies generated against last year's strain no longer neutralize this year's strain effectively — which is why you need a new flu vaccine annually. The mutations are not truly random across the protein; they cluster at antigenic sites — the exposed loops and surfaces where antibodies make contact — because mutations at these positions are the ones that provide a selective advantage by escaping immune recognition.
Antigenic shift is far more dramatic. It occurs when two different viral strains co-infect the same host cell and exchange entire genome segments through reassortment. In influenza, this can produce a virus with a completely novel hemagglutinin subtype that no human immune system has ever encountered. Because the entire population lacks immunity, antigenic shift can trigger pandemics — the 1918, 1957, 1968, and 2009 influenza pandemics all involved reassortment events. The distinction matters epidemiologically: drift causes seasonal epidemics within a partially immune population, while shift can cause global pandemics in a fully naive population.
Beyond influenza, pathogens use additional evasion strategies. Molecular mimicry involves expressing surface molecules that structurally resemble host proteins, making the immune system reluctant to attack them — doing so would risk autoimmunity. Trypanosomes take a different approach: they maintain a library of hundreds of genes encoding variant surface glycoproteins (VSGs) and systematically switch which one is expressed, presenting the immune system with a moving target that sustains chronic infection. HIV combines high mutation rates with targeting CD4+ T cells themselves, dismantling the very immune cells coordinating the response against it. Understanding these evasion mechanisms explains why some infections become chronic, why certain vaccines require frequent updating, and why vaccine design for highly variable pathogens like HIV remains one of immunology's greatest challenges.